Hong Kong is Asia’s largest and the world’s second largest destination for biotech companies wanting to go public. Amidst the backdrop of Covid-19 and changes in the political and regulatory environment in 2021, companies have forged on to make a splash on the HKEX. Here are 10 of them, ranked by the size of their IPOs.
